| Blood Test |
Specimen |
Conventional Units |
SI Units |
| 1-10 |
|
1,25-dihydroxyvitamin D [1,25(OH)2D] |
Plasma |
16–65 pg/mL |
40–160 pmol/L |
|
11-deoxycortisol (compound S) |
Plasma |
<1 mg/dL |
<30 nmol/L |
|
17-hydroxyprogesterone; men |
Plasma |
0.06–3.0 mg/L |
0.2–9.0 nmol/L |
|
17-hydroxyprogesterone; women follicular phase |
Plasma |
0.2–1.0 mg/L |
0.6–3 nmol/L |
|
17-hydroxyprogesterone; women luteal phase |
Plasma |
0.5–3.5 mg/L |
1.5–10.6 nmol/L |
|
25-hydroxyvitamin D [25(OH)D] |
Plasma |
8–80 ng/mL |
20–200 nmol/L |
|
A top |
|
Acetoacetate |
Plasma |
<3 mg/dL |
<0.3 mmol/L |
|
Adrenocorticotropin (ACTH), 8am |
Plasma |
9–52 pg/mL |
7–27–27 pmol/L |
|
Alanine Aminotransferase (ALT, SGPT) |
Serum |
0–35 U/L |
0–0.58 mkat/L |
|
Albumin |
Serum |
3.5–5.5 g/dL |
35–55 g/L |
|
Aldolase |
Serum |
<8.1 U/L |
<135 nkat/L |
|
Aldosterone |
Urine |
5–19 mg/d |
14–53 nmol/d |
|
Aldosterone, 8am, (patient supine, 100 mmol/L Na+ and 60–100 mmol/L K+
intake) |
Plasma |
<8 ng/dL |
<220 pmol/L |
|
Alpha fetoprotein (adult): α-fetoprotein |
Serum |
<30 ng/mL |
<30 mg/L |
|
Alpha1 antitrypsin (α1-antitrypsin) |
Serum |
85–213 mg/dL |
0.8–2.1 g/L |
|
Ammonia, as NH3 |
Serum |
10–80 mg/dL |
0–47 mmol/L |
|
Amylase |
Serum |
60–150 U/L |
0.8–3.2 mkat/L |
|
Androstenedione; men |
Plasma |
0.8–1.3 ng/mL |
3.0–5.0 nmol/L |
|
Androstenedione; women |
Plasma |
1–2 ng/mL |
3.5–7.0 nmol/L |
|
Angiotensin II, 8am |
Plasma |
10–30 pg/mL |
10–30 nmol/L |
|
Angiotensin-converting enzyme (ACE) |
Serum |
<40 U/L |
<670 nkat/L |
|
Antinuclear antibody agglutination |
Serum |
<1:80 titer |
<1:80 titer |
|
Arginine vasopressin (AVP), random fluid intake |
Plasma |
1.5–6.0 ng/L |
1.4–5.6 pmol/L |
|
Arterial blood gas [HCO3–] |
Arterial Blood |
21–30 meq/L |
21–28 mmol/L |
|
Arterial blood gas PCO2 |
Arterial Blood |
35–45 mmHg |
4.7–5.9 kPa |
|
Arterial blood gas pH |
Arterial Blood |
|
7.38–7.44 |
|
Arterial blood gas PO2 |
Arterial Blood |
80–100 mmHg |
11–13 kPa |
|
Ascorbic acid (Vitamin C) |
Serum |
0.4–1.0 mg/dL |
23–57 mmol/L |
|
Aspartate Aminotransferase (AST, SGOT) |
Serum |
0–35 U/L |
0–0.58 mkat/L |
|
AVP (Arginine vasopressin), random fluid intake |
Plasma |
1.5–6.0 ng/L |
1.4–5.6 pmol/L |
|
B top |
|
Bands |
Blood |
0–4% |
0–0.04 |
|
Basophils (BASO) |
Blood |
0–2% |
0–0.02 |
|
Beta-Hydroxybutyrate: β-hydroxybutyrate |
Plasma |
<3 mg/dL |
<300 mmol/L |
|
Bilirubin, Direct |
Serum |
0.1–0.3 mg/dL |
1.7–5.1 mmol/L |
|
Bilirubin, Indirect |
Serum |
0.2–0.7 mg/dL |
3.4–12 mmol/L |
|
Bilirubin, total |
Serum |
0.3–1.0 mg/dL |
5.1–17 mmol/L |
|
Bleeding time (Simplate) |
Blood |
<7 min |
<7 min |
|
Blood urea nitrogen (BUN) |
Serum |
10–20 mg/dL |
3.6–7.1 mmol/L |
|
C top |
|
Calcitonin Men |
Plasma |
<13.8 pg/mL |
<13.8 ng/L |
|
Calcitonin Women |
Plasma |
<6.4 pg/mL |
<6.4 ng/L |
|
Calcium |
Serum |
9–10.5 mg/dL |
2.25–2.62 mmol/L |
|
Calcium, ionized |
Blood |
4.5–5.6 mg/dL |
1.1–1.4 mmol/L |
|
Carbon dioxide content |
Serum |
23–28 meq/L |
23–28 mmol/L |
|
Carbon dioxide tension (PCO2) |
Arterial blood (sea level) |
35–45 mmHg |
4.7–5.9 kPa |
|
Carboxyhemoglobin non-smoker |
Blood |
0–2.3% |
0–0.023 |
|
Carboxyhemoglobin smoker |
Blood |
2.1–4.2% |
0.021–0.042 |
|
Carotene |
Serum |
75–300 mg/dL |
1.4–5.6 mmol/L |
|
Carotenoids |
Serum |
50–300 mg/dL |
0.9–5.6 mmol/L |
|
Ceruloplasmin |
Serum |
27–37 ng/dL |
270–370 mg/L |
|
Chloride |
Serum |
98–106 meq/L |
98–106 mmol/L |
|
Cholesterol (see Table in Lipoproteins page) |
|
Chorionic gonadotropin, Beta-subunit (B-hCG), men and nonpregnant women |
Plasma |
<3 mIU/mL |
<3 IU/L |
|
Copper |
Serum |
70–155 mg/dL |
11–24 mmol/L |
|
Cortisol am |
Plasma |
5–25 mg/dL |
140–690 nmol/L |
|
Cortisol pm |
Plasma |
3–12 mg/dL |
80–330 nmol/L |
|
Cortisol Urinary Free |
Urine |
10–50 mg/d |
25–140 nmol/d |
|
Creatine kinase-MB |
Serum |
< 3% of total |
<0.03 of total |
|
Creatinine |
Serum |
<1.5 mg/dL |
<133 mmol/L |
|
Creatinine kinase (CK); females |
Serum |
<190 U/L |
<3.17 mkat/L |
|
Creatinine kinase (CK); males |
Serum |
<235 U/L |
<3.92 mkat/L |
|
D top |
|
Dehydroepiandrosterone (DHEA) |
Plasma |
2–9 ng/dL |
7–31 nmol/L |
|
Delta-aminolevulinic acid |
Serum |
<20 mg/dL |
<1.5 mmol/L |
|
DHEA (Dehydroepiandrosterone) |
Plasma |
2–9 ng/dL |
7–31 nmol/L |
|
DHEA sulfate |
Plasma |
500–2500 mg/dL |
1.3–6.8 mmol/L |
|
E top |
|
EOS (eosinophils) |
Blood |
0–7% |
0–0.07 |
|
Eosinophils (EOS) |
Blood |
0–7% |
0–0.07 |
|
Erythrocyte count |
Blood |
4.15–4.90 × 106/mm3 |
4.15–4.90 × 1012/L |
|
Erythropoietin |
Serum |
|
5–36 U/L |
|
Estradiol; men |
Plasma |
<50 pg/mL |
<180 pmol/L |
|
Estradiol; women (higher at ovulation) |
Plasma |
20–60 pg/mL |
70–220 pmol/L |
|
Ethanol |
Blood |
<0.005% |
<0.005% |
|
Euglobulin lysis time |
Blood |
>2 h |
>2 h |
|
F top |
|
Fatty acids, free (nonesterified) |
Plasma |
<18 mg/dL |
180 mg/L |
|
Ferritin; men |
Serum |
15–400 ng/mL |
15–400 mg/L |
|
Ferritin; women |
Serum |
10–200 ng/mL |
10–200 mg/L |
|
Fibrinogen |
Plasma |
150–400 mg/dL |
1.5–4 g/L |
|
Folate |
Serum |
2.5–20 ng/mL |
>4.3 nmol/L |
|
Folate, red cell |
Red blood cells |
160–855 ng/mL |
>95 nmol/L |
|
Folic acid |
Red cell |
150–450 ng/mL cells |
340–1020 nmol/L cells |
|
Folic acid |
Serum |
3–16 ng/mL cells |
7–36 nmol/L cells |
|
Follicle-stimulating hormone (FSH); men |
Plasma |
0.9–15 mIU/mL |
0.9–15 IU/L |
|
Follicle-stimulating hormone (FSH); postmenopausal women |
Plasma |
34–96 mIU/mL |
34–96 IU/L |
|
Follicle-stimulating hormone (FSH); women ovulatory surge |
Plasma |
2.3–21 mIU/mL |
2.3–21 IU/L |
|
Follicle-stimulating hormone (FSH); women mature, premenopausal, except at
ovulation |
Plasma |
1.4–9.6 mIU/mL |
1.4–9.6 IU/L |
|
FSH (Follicle-stimulating hormone) |
Plasma |
0.9–15 mIU/mL |
0.9–15 IU/L |
|
G top |
|
Gastrin |
Serum |
40–180 pg/mL |
40–180 ng/L |
|
Glucagon |
Plasma |
50–100 pg/mL |
50–100 ng/L |
|
Glucose fasting (diabetes mellitus) |
Plasma |
>140 mg/dL |
>7.8 mmol/L |
|
Glucose fasting (normal) |
Plasma |
75–115 mg/dL |
4.2–6.4 mmol/L |
|
Glucose: 2 hour post prandial (impaired glucose tolerance) |
Plasma |
140–200 mg/dL |
7.8–11.1 mmol/L |
|
Glucose: 2 hour post prandial (normal) |
Plasma |
<140 mg/dL |
<7.8 mmol/L |
|
Glucose: 2 hour postprandial (diabetes mellitus) |
Plasma |
>200 mg/dL |
>11.1 mmol/L |
|
Glucose-6-phosphate dehydrogenase |
Blood |
12.1 ± 2 IU/g Hb |
0.78 ± 0.13 MU/mol Hb |
|
Growth hormone, after 100 g oral glucose |
Serum |
<2 ng/mL |
<2 mg/L |
|
H top |
|
Ham's test (acid serum) |
Blood |
Negative |
Negative |
|
Haptoglobin (serum) |
Blood |
50–220 mg/dL |
0.5–2.2 g/L |
|
HbF (Hemoglobin, fetal) |
Blood |
<2% |
<0.02 |
|
HCT; females (hematocrit) |
Blood |
37–48% |
0.37–0.48 |
|
HCT; males (Hematocrit) |
Blood |
42–52% |
0.42–0.52 |
|
Hematocrit (HCT); females |
Blood |
37–48% |
0.37–0.48 |
|
Hematocrit (HCT); males |
Blood |
42–52% |
0.42–0.52 |
|
Hemoglobin A1c |
Whole Blood |
3.8–6.4% |
0.038–0.064 |
|
Hemoglobin A2 (HbA2) |
Blood |
1.5–3.5% |
0.015–0.035 |
|
Hemoglobin; female |
Blood |
12–16 g/dL |
120–160 g/L |
|
Hemoglobin; male |
Blood |
14–18 g/dL |
140–180 g/L |
|
Hemoglobin; whole blood females |
Blood |
12–16 g/dL |
7.4–9.9 mmol/L |
|
Hemoglobin; whole blood males |
Blood |
13–18 g/dL |
8.1–11.2 mmol/L |
|
Hemoglobin; fetal (HbF) |
Blood |
<2% |
<0.02 |
|
I top |
|
Insulin, fasting |
Serum or Plasma |
6–26 mU/mL |
43–186 pmol/L |
|
Iron |
Serum |
60–150 mg/dL |
11–29 mmol/L |
|
Iron Saturation |
Serum |
20–45% |
0.2–0.45 |
|
Iron-binding capacity |
Serum |
250–370 mg/dL |
45–66 mmol/L |
|
L top |
|
Lactate (Lactic acid) |
Plasma |
6–16 mg/dL |
0.67–1.8 mmol/L |
|
Lactate dehydrogenase (LDH) |
Serum |
100–190 U/L |
1.7–3.2 mkat/L |
|
Lactate dehydrogenase isoenzymes Fraction 1 (of total) |
Serum |
14–26% |
0.14–0.25 |
|
Lactate dehydrogenase isoenzymes Fraction 2 (of total) |
Serum |
29–39% |
0.29–0.39 |
|
Lactate dehydrogenase isoenzymes Fraction 3 (of total) |
Serum |
20–26% |
0.20–0.25 |
|
Lactate dehydrogenase isoenzymes Fraction 4 (of total) |
Serum |
8–16% |
0.08–0.16 |
|
Lactate dehydrogenase isoenzymes Fraction 5 (of total) |
Serum |
6–16% |
0.06–0.16 |
|
LAP (leukocyte alkaline phosphatase) |
Blood |
13–100 m/L |
0.2–1.6 mkat/L |
|
LDH (Lactate dehydrogenase) |
Serum |
100–190 U/L |
1.7–3.2 mkat/L |
|
Lead |
Serum |
<40 mg/dL |
<1.9 mmol/L |
|
Leukocyte Alkaline phosphatase (LAP) |
Blood |
13–100 m/L |
0.2–1.6 mkat/L |
|
Leukocyte Count (WBC, white blood cell count) |
Blood |
4.3–10.8 × 103/mm3 |
4.3–10.8 × 109/L |
|
Lipase |
Serum |
0–160 U/L |
0–2.66 mkat/L |
|
Lipoprotein (a) |
Serum |
0–3 mg/dL |
0–300 mg/L |
|
Lutenizing hormone; men |
Serum |
1.3–13 mIU/mL |
1.3–13 IU/L |
|
Lutenizing hormone; women mature, premenopausal, except at ovulation |
Serum |
0.8–26 mIU/mL |
0.8–26 IU/L |
|
Lutenizing hormone; women ovulatory surge |
Serum |
25–57 mIU/mL |
25–57 IU/L |
|
Lutenizing hormone; women postmenopausal |
Serum |
40–104 mIU/mL |
40–104 IU/L |
|
Lymphocytes (Lymphs) |
Blood |
16–45% |
0.16–0.45 |
|
Lymphs (lymphocyes) |
Blood |
16–45% |
0.16–0.45 |
|
M top |
|
Magnesium |
Serum |
1.8–3 mg/dL |
0.8–1.2 mmol/L |
|
MCH (mean corpuscular hemoglobin) |
Blood |
28–33 pg/cell |
28–33 pg/cell |
|
MCHC (mean corpuscular hemoglobin concentration) |
Blood |
32–36 g/dL |
320–360 g/L |
|
MCV (mean corpuscular volume) |
Blood |
86–98 mm3 |
86–98 fl |
|
Mean corpuscular hemoglobin (MCH) |
Blood |
28–33 pg/cell |
28–33 pg/cell |
|
Mean corpuscular hemoglobin concentration (MCHC) |
Blood |
32–36 g/dL |
320–360 g/L |
|
Mean corpuscular volume (MCV) |
Blood |
86–98 mm3 |
86–98 fl |
|
Mono (monocytes) |
Blood |
4–10% |
0.04–0.10 |
|
Monocytes (Mono) |
Blood |
4–10% |
0.04–0.10 |
|
Myoglobin |
Serum |
<55 ng/L |
<55 mg/L |
|
N top |
|
Neutrophils (Poly, PMN) |
Blood |
45–74% |
0.45–0.74 |
|
O top |
|
Osmolality |
Plasma |
285–295 mosmol/kg serum water |
285–295 mmol/kg serum water |
|
Oxygen percent saturation (sea level) |
B, arterial |
97% |
0.97 mol/mol |
|
Oxygen tension (PO2) |
Blood |
80–100 mmHg |
11–13 kPa |
|
P top |
|
Parathyroid hormone |
Serum |
10–60 pg/mL |
10–60 ng/L |
|
Parathyroid hormone-related protein |
Plasma |
<1.3 pmol/L |
<1.3 pmol/L |
|
pH |
Arterial Blood |
7.38–7.44 |
7.38–7.44 |
|
Phosphatase, acid |
Serum |
0–5.5 U/L |
0.90 nkat/L |
|
Phosphatase, alkaline |
Serum |
30–120 U/L |
0.5–2.0 nkat/L |
|
Phosphorus, inorganic |
Serum |
3–4.5 mg/dL |
1.0–1.4 mmol/L |
|
Platelets |
Blood |
130,000–400,000/mm3 |
130–400 × 109/L |
|
PMN (neutrophils, Poly) |
Blood |
45–74% |
0.45–0.74 |
|
Poly (neutrophils, PMN) |
Blood |
45–74% |
0.45–0.74 |
|
Potassium |
Serum |
3.5–5.0 meq/L |
3.5–5.0 mmol/L |
|
Progesterone; men, prepubertal girls, preovulatory women, postmenopausal
women |
Plasma |
<2 ng/mL |
<6 nmol/L |
|
Progesterone; women, luteal, peak |
Plasma |
2–20 ng/mL |
6–60 nmol/L |
|
Prolactin |
Serum |
2–15 ng/mL |
2–15 mg/L |
|
Prostate specific antigen >40 years |
Serum |
0.0–4.0 ng/mL |
0.0–4.0 mg/L |
|
Prostate specific antigen; male <40 years |
Serum |
0.0–2.0 ng/mL |
0.0–2.0 mg/L |
|
Prostate-specific antigen (PSA); female |
Serum |
<0.5 ng/mL |
<0.5 mg/L |
|
Protein, total |
Serum |
5.5–8.0 g/dL |
55–80 g/L |
|
Protoporphyrin, free erythrocyte (FEP) |
Blood |
16–36 mg/dL of red blood cells |
0.28–0.64 mmol/L of red blood cells |
|
PSA, free, in males 45–75 years, with PSA values between 4 and 20 mg/mL |
Serum |
>25% associated with benign prostatic hyperplasia |
>0.25 associated with benign prostatic hyperplasia |
|
Pyruvate |
Plasma |
0.5–1.5 mg/dL |
60–170 mmol/L |
|
R top |
|
RDW (Red cell distribution width) |
Blood |
13–15% |
0.13–0.15 |
|
Red cell distribution width (RDW) |
Blood |
13–15% |
0.13–0.15 |
|
Reverse T3 (rT3) |
Serum |
2.6–18.9 ng/dL |
0.04–0.29 nmol/L |
|
Rheumatoid factor |
Serum |
<40 IU/mL |
<40 kIU/L |
|
rT3 (Reverse T3) |
Serum |
2.6–18.9 ng/dL |
0.04–0.29 nmol/L |
|
S top |
|
Sodium |
Serum |
136–145 meq/L |
136–145 mmol/L |
|
Sucrose hemolysis |
Blood |
Negative |
Negative |
|
T top |
|
T3 (Free) |
Serum |
230–420 pg/dL |
3.5–6.5 pmol/L |
|
T3 (Total) |
Serum |
60–181 ng.dL |
0.9–2.8 nmol/L |
|
Testosterone; men |
Plasma |
3–10 ng/mL |
10–35 nmol/L |
|
Testosterone; women |
Plasma |
<1 ng/mL |
<3.5 nmol/L |
|
Thyroglobulin |
Serum |
0–60 ng/mL |
0–60 mg/L |
|
Thyroid stimulating hormone (TSH) |
Serum |
0.4–5.0 mU/mL |
0.4–5.0 mU/L |
|
Thyroxine (T4) |
Serum |
5–12 mg/dL |
64–154 nmol/L |
|
Transferrin |
Serum |
230–390 mg/dL |
2.3–3.9 g/L |
|
Triglycerides |
Serum |
<160 mg/dL |
<1.8 mmol/L |
|
Troponin I |
Serum |
0–0.4 ng/mL |
0–0.4 mg/L |
|
Troponin T |
Serum |
0–0.1 ng/mL |
0–0.1 mg/L |
|
TSH (Thyroid stimulating hormone) |
Serum |
0.4–5.0 mU/mL |
0.4–5.0 mU/L |
|
U top |
|
Uric acid; men |
Serum |
2.5–8.0 mg/dL |
150–480 mmol/L |
|
Uric acid; women |
Serum |
1.5–6.0 mg/dL |
90–360 mmol/L |
|
V top |
|
Vitamin A |
Serum |
20–100 mg/dL |
0.7–3.5 mmol/L |
|
Vitamin B1 (thiamine) |
Serum |
0–2 mg/dL |
0–75 nmol/L |
|
Vitamin B12 |
Serum |
200–600 pg/mL |
148–443 pmol/L |
|
Vitamin B2 (riboflavin) |
Serum |
4–24 mg/dL |
106–638 nmol/L |
|
Vitamin B6 |
Plasma |
5–30 ng/ml |
20–121 nmol/L |
|
Vitamin C (ascorbic acid) |
Serum |
0.4–1.0 mg/dL |
23–57 mmol/L |
|
Vitamin D3: 1,25-dihydroxy |
Serum |
25–45 pg/mL |
60–108 pmol/L |
|
Vitamin D3: 25-hydroxy;
winter |
Plasma |
14–42 ng/mL |
34.9–105 nmol/L |
|
Vitamin D3: 25-hydroxy;
summer |
Plasma |
15–80 ng/mL |
37.4–200 nmol/L |
|
Vitamin E |
Serum |
5–18 mg/mL |
12–42 mmol/L |
|
W top |
|
von Willebrand's antigen |
Blood |
60–150% |
60–150% |
|
WBC (leukocyte count, white blood cell count) |
Blood |
4.3–10.8 × 103/mm3 |
4.3–10.8 × 109/L |
|
Westergren Sed Rate; females < 50 y/o |
Blood |
0–20 mm/h |
0–20 mm/h |
|
Westergren Sed Rate; females > 50 y/o |
Blood |
0–30 mm/h |
0–30 mm/h |
|
Westergren Sed Rate; males < 50 y/o |
Blood |
0–15 mm/h |
0–15 mm/h |
|
Westergren Sed Rate; males >50 y/o |
Blood |
0–20 mm/h |
0–20 mm/h |
|
White blood cell count (leukocyte count, WBC) |
Blood |
4.3–10.8 × 103/mm3 |
4.3–10.8 × 109/L |
|
Z top |
|
Zinc |
Serum |
75–120 mg/dL |
11.5–18.5 mmol/L |
Michael
W. King, Ph.D / IU School of Medicine / miking at iupui.edu